PSAT1 and colorectal cancer: Previous research reported that the dysregulation of PSAT1 activity may alter glucose and glutamine utilization in serine biosynthesis, promoting tumorigenesis and chemoresistance in colorectal cancers given that PSAT1 is a metabolism-related gene [31, 32].